Nitto Avecia
Kevin Mahan is a seasoned professional in the field of oligonucleotide manufacturing, currently serving as the Senior Manufacturing Manager at Nitto Avecia since January 2013. In this role, Kevin oversees the planning and execution of manufacturing activities while emphasizing safety and compliance, and leading the training and development of the production team. Kevin has held various positions within Nitto Avecia, including Manufacturing Manager and Oligonucleotides Production Group Leader, focusing on multi-million dollar operations for GMP therapeutic oligonucleotides. Prior experience includes technical leadership roles at GIRINDUS America, production technician duties at Nanosphere, and chemist roles at Pierce-Milwaukee and Abbott Laboratories. Kevin holds a BS in Biology from the University of Illinois Urbana-Champaign.
This person is not in any offices
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.